InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,587.60
(
-0.13%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
82.95
(
-0.63%
)
Bitcoin
64,091.02
(
1.46%
)
Post# of 1434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rikic

Send PM Follow Ignore
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

rikic

Re: None

Thursday, 09/22/2016 11:03:11 AM

Thursday, September 22, 2016 11:03:11 AM

Post# of 1434
Aradigm Announces Last Patient Dosing Visit in ORBIT-3 and ORBIT-4 Phase 3 Studies of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis Patients

http://investor.aradigm.com/releasedetail.cfm?ReleaseID=990452
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up